Biogen Idec Inc said on Tuesday its fourth-quarter earnings rose nearly 48 percent, driven by increased sales of its multiple sclerosis drugs and lower expenses.

Caroline Alphonso Hamilton, Ont. - Published on Monday, Feb. 08, 2010 9:16PM EST R esearchers in Hamilton plan to begin patient trials evaluating the work of an Italian scientist whose intriguing treatment for multiple sclerosis has sparked both hope and controversy.

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis .

Biogen Idec , a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced that John R. Richert, M.D., will be joining the Company as a Senior Fellow in Neurology Research and Development and Nancy D. Richert, M.D., Ph.D., will be joining as a Fellow in Neurology Research ...

FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy with the use of Tysabri Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [02-05-2010] The U.S. Food and Drug Administration is alerting the public that the risk of developing ...

Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , has announced today that sales of its recently launched over-the-counter pain reliever , Cobroxin , totaled $583,955 for the fourth quarter ending December 31, 2009.

Fewer African Americans than Caucasians develop multiple sclerosis , statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found.

Federal health officials warned doctors Friday that the risk of a deadly brain inflammation linked to the multiple sclerosis treatment Tysabri increases with use of the drug.

"The first tablets to fight multiple sclerosis dramatically reduce the chances of symptoms returning," The Daily Telegraph has reported.

Researchers in Saskatchewan have been working toward finding the cure for multiple sclerosis and now a new campaign is aimed at speeding up the process.

Ohio Valley Chapter Receives Three Awards to Continue Mission of Service and Research Cincinnati, OH - February 1, 2010 - The Ohio Valley Chapter of the National Multiple Sclerosis Society recently received three awards complimenting our efforts to mobilize people and resources to drive a cure while addressing the challenges of everyone affected by ...

After its official launch in November 2009, the 32nd edition of the MS Read-A-Thon, for the benefit of the Multiple Sclerosis Society of Canada, Quebec Division, is off to a promising start.

Health care advocates are trying to ensure that the final reform bill--which will be sent to President Obama in February--contains protections that will enable women with chronic conditions to afford ongoing care.

A new study has revealed that the risk of developing multiple sclerosis changes with the season.

Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients and intermediates, announced it has received an Establishment Inspection Report from the U.S. Food and Drug Administration stating that Regis passed the FDA's pre-approval inspection for its manufacture of ...

Robert Douglas Jensen, age 79, of Catonsville, MD, died Thursday, January 21, 2010, due to complications of multiple sclerosis.

Scientists at the Babraham Institute have discovered a novel survival factor whose rapid transport along nerve cells is crucial for keeping them alive.

The following recalls have been announced: -Nipro Medical Corp. of Miami is recalling all GlucoPro Insulin Syringes with expiration dates before Nov.

Chemical biology news from across RSC Publishing. Interview: Finding answers in blood 27 January 2010 Dana Spence discusses the function of red blood cells and the importance of a foundation in chemistry with Jane Hordern Dana Spence is an associate professor at Michigan State University, East Lansing, US specialising in quantitative biological ...

Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration for AMPYRATM , an oral treatment to improve walking in patients with multiple sclerosis .